Healthcare provider profile · identity verified

Edward David Sledge, MD

Internal Medicine · BATON ROUGE, LA · NPI 1790703528

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	599	182
Amlodipine Besylate	Amlodipine Besylate	502	155
Rosuvastatin Calcium	Rosuvastatin Calcium	465	131
Levothyroxine Sodium	Levothyroxine Sodium	381	108
Pantoprazole Sodium	Pantoprazole Sodium	296	99
Lisinopril	Lisinopril	262	81
Losartan Potassium	Losartan Potassium	243	73
Metoprolol Succinate	Metoprolol Succinate	242	72
Metformin Hcl	Metformin Hcl	225	72
Gabapentin	Gabapentin	208	66
Hydrochlorothiazide	Hydrochlorothiazide	202	70
Omeprazole	Omeprazole	171	51
Valsartan	Valsartan	157	52
Pravastatin Sodium	Pravastatin Sodium	139	42
Furosemide	Furosemide	134	54
Trulicity	Dulaglutide	134	29
Sertraline Hcl	Sertraline Hcl	133	42
Meloxicam	Meloxicam	128	48
Trazodone Hcl	Trazodone Hcl	127	35
Potassium Chloride	Potassium Chloride	119	38
Montelukast Sodium	Montelukast Sodium	118	34
Allopurinol	Allopurinol	116	35
Tamsulosin Hcl	Tamsulosin Hcl	114	38
Escitalopram Oxalate	Escitalopram Oxalate	108	32
Jardiance	Empagliflozin	104	25
Ozempic	Semaglutide	101	25
Carvedilol	Carvedilol	96	31
Mirtazapine	Mirtazapine	96	28
Alendronate Sodium	Alendronate Sodium	95	28
Clopidogrel	Clopidogrel Bisulfate	90	22
Mounjaro	Tirzepatide	88	17
Clonazepam	Clonazepam	85	16
Fluticasone Propionate	Fluticasone Propionate	85	39
Tramadol Hcl	Tramadol Hcl	85	21
Tizanidine Hcl	Tizanidine Hcl	79	43
Glimepiride	Glimepiride	78	23
Eliquis	Apixaban	74	18
Alprazolam	Alprazolam	66	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	13
Metformin Hcl Er	Metformin Hcl	58	20
Metoprolol Tartrate	Metoprolol Tartrate	58	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	57	15
Simvastatin	Simvastatin	57	18
Esomeprazole Magnesium	Esomeprazole Magnesium	56	15
Olmesartan Medoxomil	Olmesartan Medoxomil	56	14
Zolpidem Tartrate	Zolpidem Tartrate	53	13
Benazepril Hcl	Benazepril Hcl	50	17
Buspirone Hcl	Buspirone Hcl	50	14
Diclofenac Sodium	Diclofenac Sodium	50	30
Irbesartan	Irbesartan	50	13
Albuterol Sulfate Hfa	Albuterol Sulfate	49	22
Atenolol	Atenolol	49	14
Pioglitazone Hcl	Pioglitazone Hcl	48	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	15
Ezetimibe	Ezetimibe	47	18
Donepezil Hcl	Donepezil Hcl	45	suppressed
Januvia	Sitagliptin Phosphate	45	suppressed
Duloxetine Hcl	Duloxetine Hcl	44	17
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	43	11
Ropinirole Hcl	Ropinirole Hcl	42	12
Spironolactone	Spironolactone	42	14
Celecoxib	Celecoxib	41	suppressed
Famotidine	Famotidine	39	13
Memantine Hcl	Memantine Hcl	39	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	13
Venlafaxine Hcl Er	Venlafaxine Hcl	38	12
Testosterone Cypionate	Testosterone Cypionate	37	suppressed
Etodolac	Etodolac	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Lorazepam	Lorazepam	35	suppressed
Synthroid	Levothyroxine Sodium	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	15
Doxazosin Mesylate	Doxazosin Mesylate	33	suppressed
Finasteride	Finasteride	33	13
Methylprednisolone	Methylprednisolone	32	32
Bupropion Xl	Bupropion Hcl	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Chlorthalidone	Chlorthalidone	30	11
Nifedipine Er	Nifedipine	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Linzess	Linaclotide	29	suppressed
Ranolazine Er	Ranolazine	28	suppressed
Repatha Sureclick	Evolocumab	28	suppressed
Aripiprazole	Aripiprazole	27	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	22
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	12
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Naproxen	Naproxen	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Baclofen	Baclofen	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Ramipril	Ramipril	19	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	18	suppressed
Azithromycin	Azithromycin	18	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Temazepam	Temazepam	17	suppressed
Topiramate	Topiramate	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Diazepam	Diazepam	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Estradiol	Estradiol	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	11
Cephalexin	Cephalexin	12	12
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxazepam	Oxazepam	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Steglatro	Ertugliflozin Pidolate	12	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	11	suppressed
Cholestyramine Light	Cholestyramine	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Invokana	Canagliflozin	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error